Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
35 results
D2.521 - Reshaping Allergy Assessment Pathways In The United Kingdom: Modeling System-Level Gains Through Discrete Event Simulation
D2.522 - An Observational Study of techniques of Intanasal Spray in Allergic Rhinitis
D2.524 - How much does wheat oral immunotherapy improve quality of life?
D2.530 - Digital patient-reported data uncover key clinical features of mastocytosis: insights from the MASTHAVE App
D2.532 - Does Bathing Frequency Matter in Pediatric Atopic Dermatitis? Insights from Real-Life Practice
D2.533 - Characterizing Elderly Asthma Hospitalizations: Insights into Treatment Gaps and Outcomes; A Real‑World Study Using the MIMIC‑IV Dataset
D2.523 - Dyadic parenting stress and marital communication among parents of young children with food allergies
D2.527 - Lessening the food allergy burden through education: A Canadian focus
D2.528 - Corticophobia Among Caregivers of Children with Atopic Diseases: Causes and Outcomes
D2.529 - Asymptomatıc QT Prolongatıon Developıng After Antıhıstamıne Use
D2.531 - Expert Panel Discussion on a New Oral On-Demand Treatment in Hereditary Angioedema
D2.536 - Seasonal Influenza Vaccination: Uptake Rate, Profile, and Motivating Factors Among Healthcare Workers
D2.537 - Advances in Drug Allergy & Penicillin Testing Phase 2 (ADAPT-2): an AI-powered drug allergy educational initiative spanning across 4 localities
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
D3.153 - Add-on Dupilumab therapy significantly reduces severe asthma exacerbations and emergency visits in patients with severe persistent asthma requiring oral corticosteroids for maintenance therapy: our experience in Réunion Island
D3.154 - Trends in Bronchial Asthma Incidence in Crimea: Analysis from 2017-2024 with Age-Specific Insights
D3.155 - Th2–Th17 immune shift following dupilumab therapy
D3.156 - Pulmonary embolism in a young asthma patient
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download